申请人:Pfizer Inc.
公开号:US06200978B1
公开(公告)日:2001-03-13
Compounds of the formula (I)—shown below—are described.
The compounds are useful in the manufacture of a pharmaceutical composition for preventing or treating inflammatory diseases such as arthritis, psoriasis, asthma, or inflammatory bowel disease, disorders of respiratory function, gastrointestinal disorders such as functional bowel disease, functional GI disorders such as irritable bowel syndrome, functional diarrhoea, functional distension, functional pain, non-ulcerogenic dyspepsia or others associated with disorders of motility or secretion, urogenital tract disorders such as incontinence, as analgesics for treating pain including non-somatic pain, or as immunosuppressants to prevent rejection in organ transplant and skin graft.
化合物的公式(I)如下所示。这些化合物在制造用于预防或治疗炎症性疾病,如关节炎、牛皮癣、哮喘、炎症性肠病、呼吸功能障碍、胃肠功能紊乱、功能性肠道疾病、功能性胃肠障碍(如肠易激综合征)、功能性腹泻、功能性胀气、功能性疼痛、非溃疡性消化不良或与运动或分泌紊乱相关的其他疾病方面非常有用,还可用作镇痛药物,用于治疗包括非体感疼痛在内的疼痛,或作为免疫抑制剂,以预防器官移植和皮肤移植中的排斥反应。